Private area
Contact Us
Total Visits
| Views | |
|---|---|
| Efficacy ... | 156 |
Total Visits Per Month
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| Efficacy ... | 13 | 11 | 0 | 5 | 8 | 12 | 6 |
File Visits
| Views | |
|---|---|
| efficacy_neratinib_plus_capecitabine_subgroup_patients_central_nervous_system_involvement_nala_trial_2021.pdf | 67 |
| efficacy_neratinib_plus_capecitabine_subgroup_patients_central_nervous_system_involvement_nala_trial_2021_figures.pdf | 44 |
| efficacy_neratinib_plus_capecitabine_subgroup_patients_central_nervous_system_involvement_nala_trial_2021_taules.pdf | 32 |
Top country views
| Views | |
|---|---|
| United States | 52 |
| Singapore | 22 |
| Brazil | 17 |
| China | 11 |
| Spain | 9 |
| Germany | 6 |
| Hong Kong | 4 |
| Argentina | 3 |
| Australia | 3 |
| Vietnam | 3 |
Top cities views
| Views | |
|---|---|
| Singapore | 18 |
| Beijing | 9 |
| Chandler | 7 |
| Ashburn | 6 |
| Hong Kong | 4 |
| Barcelona | 3 |
| Sydney | 3 |
| Berlin | 2 |
| Hanoi | 2 |
| Mumbai | 2 |
